Preclinical characterization of crac channel inhibitors for the treatment of alzheimer's disease - vivreon biosciences, LLC 4940 carroll canyon RD., STE. 110 SAN diego, CA 92121
Ended Project Grant Awarded Last action
- Award ID
- R44AG061995
- Recipient
-
Vivreon Biosciences LLC UEI P935LHN98ZV9
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,326,544
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $50,000 | |
| Amendment | $1,223,378 | |
| Amendment | $1,223,378 | |
| Amendment | $1,276,596 | |
| Amendment | $1,276,596 | |
| Original award | $1,276,596 |
Quick answers
Who received award R44AG061995?
R44AG061995 was awarded to Vivreon Biosciences LLC by National Institute on Aging (National Institutes of Health) on September 15, 2022.
How much is award R44AG061995 worth?
$6,326,544 has been obligated on R44AG061995.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award